| 30.89 -1.14 (-3.56%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 39.26  |
1-year : | 45.86 |
| Resists | First : | 33.62 |
Second : | 39.26 |
| Pivot price | 26.61 |
|||
| Supports | First : | 19.95 |
Second : | 11.5 |
| MAs | MA(5) : | 29.61 |
MA(20) : | 24.52 |
| MA(100) : | 21.68 |
MA(250) : | 38.97  |
|
| MACD | MACD : | 2 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 91.4 |
D(3) : | 93.9 |
| RSI | RSI(14): 62 |
|||
| 52-week | High : | 74.06 | Low : | 11.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CTEV ] has closed below upper band by 14.0%. Bollinger Bands are 22.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 33.65 - 33.82 | 33.82 - 33.93 |
| Low: | 30 - 30.21 | 30.21 - 30.35 |
| Close: | 30.59 - 30.91 | 30.91 - 31.11 |
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Fri, 12 Jun 2026
Is Claritev Corp (CTEV) a Bargain After 3.6% Drop? GF Value Says Undervalued - GuruFocus
Thu, 11 Jun 2026
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View - Yahoo Finance
Wed, 10 Jun 2026
Insider Buying: Nutter Carol Acquires Shares of Claritev Corp (C - GuruFocus
Wed, 10 Jun 2026
Claritev SVP Carol Nutter buys $24,856 in company stock By Investing.com - Investing.com South Africa
Wed, 10 Jun 2026
Claritev SVP Carol Nutter buys $24,856 in company stock - Investing.com
Wed, 10 Jun 2026
Claritev (CTEV) chief people officer buys 875 company shares - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 17 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 7.4 (%) |
| Held by Institutions | 90.9 (%) |
| Shares Short | 1,190 (K) |
| Shares Short P.Month | 1,230 (K) |
| EPS | -17.33 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -14.19 |
| Profit Margin | -29.3 % |
| Operating Margin | 7.5 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 5.8 % |
| Gross Profit (p.s.) | 42.03 |
| Sales Per Share | 57.4 |
| EBITDA (p.s.) | 31.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 102 (M) |
| Levered Free Cash Flow | 109 (M) |
| PE Ratio | -1.79 |
| PEG Ratio | 0 |
| Price to Book value | -2.18 |
| Price to Sales | 0.53 |
| Price to Cash Flow | 5.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|